Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06319157

Minimal Access Versus Conventional Latissimus Dorsi Flap Harvest for Breast Reconstruction

A Randomized Controlled Study of Minimal Access Latissimus Dorsi Flap Harvest for Breast Reconstruction Versus Conventional Approaches in the Treatment of Early Breast Cancer

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
94 (estimated)
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
Sex
Female
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

For patients refusing implants for breast reconstruction after cancer surgery, autologous tissue flap reconstruction using the latissimus dorsi muscle is an alternative. Conventional surgery leaves a long incision on the back, affecting aesthetics and quality of life. Minimal access techniques result in a smaller, more concealable scar. While previous studies suggest its safety and effectiveness, most are retrospective. To further validate patient satisfaction and short-term outcomes, a prospective, randomized controlled trial comparing minimal access with conventional surgery is planned. The primary endpoint is Breast Q-satisfaction with back score at 6 months. Secondary outcomes include other Breast Q subscales, surgical metrics, and complications. The study aims to enroll 94 patients in total, providing evidence for surgical decision-making in breast cancer reconstruction.

Conditions

Interventions

TypeNameDescription
DEVICEminimal access breast reconstruction with a latissimus dorsi muscle flapminimal access breast reconstruction with a latissimus dorsi muscle flap
DEVICEconventional breast reconstruction with a latissimus dorsi muscle flapconventional breast reconstruction with a latissimus dorsi muscle flap

Timeline

Start date
2024-03-01
Primary completion
2028-11-01
Completion
2028-11-01
First posted
2024-03-19
Last updated
2024-03-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06319157. Inclusion in this directory is not an endorsement.